Study title: Double-blind parallel multisite study of the safety and efficacy of cetirizine 10mg QAM and terfenadine 60mg BID vs placebo in the treatment of patients with seasonal allergic rhinitis Summary of stuides 86-N-0051, -0052, -0053, -0054
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: CETIRIZINE | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: SAR-5 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |